The clinical course of diseases was influenced by the status of the patient’s immunodeficiency; thus, the occurrence of IgM antibodies to CMV and T. gondii and clinical presentation of CMV and/or Toxoplasma infection suggest ongoing immunosuppression in all our patients and possible reactivation of both infections. The gene discussed is CD40LG; the disease is immunodeficiency disease.